View More Recent Stories

Aug 8, 2024 07:00AM Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q2 EPS by 34c

Jul 11, 2024 10:30AM H.C. Wainwright Reiterates Buy Rating on Amylyx Pharmaceuticals inc. (AMLX)

Jul 10, 2024 07:00AM Amylyx Pharmaceuticals (AMLX) Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation

Jun 24, 2024 06:36AM H.C. Wainwright Reiterates Buy Rating on Amylyx Pharmaceuticals inc. (AMLX)

View More Recent Stories